Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.38.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.38.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.38.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XAVORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XAVENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAVENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAVNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BE.1.4.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BE.1.4.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.1.4.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.1.4.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBC.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBC.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBC.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BM.4.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BM.4.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BM.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.4.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.20ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.20ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.20NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.77ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.77ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-16984.7China
BA.2.77ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.77NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CP.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CP.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CP.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CP.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FC.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FC.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FC.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FC.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BY.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BY.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BY.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BY.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.17ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.7.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.17NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.123 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.123 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.123 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.123 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.27ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.27ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used